Cerebral perfusion pressure

10 min read Last updated April 8, 2026

Surgical approach (where CPP targets commonly matter)

  • CPP is not an operation; it is a physiological target used during neurosurgery and neurocritical care.
  • Common surgical contexts where CPP management is central
    • Traumatic brain injury: decompressive craniectomy, evacuation of extradural/subdural haematoma, contusionectomy
    • Aneurysmal SAH: clipping; endovascular coiling (IR rather than surgery) with BP/CPP targets for vasospasm
    • Tumour surgery: craniotomy with brain relaxation strategies; avoidance of hypotension
    • Hydrocephalus: EVD insertion/VP shunt; ICP control and CPP maintenance

Anaesthetic management (typical when CPP is a key target)

  • Type of anaesthesia
    • Usually GA for TBI/craniotomy/aneurysm surgery; sedation/GA for EVD depending on urgency and airway
    • Regional techniques have limited role; scalp block may reduce sympathetic surges and ICP
  • Airway
    • ETT is standard (control PaCO₂, oxygenation, airway protection). SGA generally avoided in raised ICP or full stomach.
  • Duration
    • Variable: EVD 30–60 min; haematoma evacuation 1–3 h; tumour 3–8 h; aneurysm clipping 3–6 h; decompressive craniectomy 2–4 h.
  • How painful
    • Craniotomy: moderate–severe (scalp, muscle); requires multimodal analgesia; avoid hypercapnia/hypertension from pain.
    • EVD: mild–moderate; local anaesthetic infiltration ± short GA/sedation.
  • Core aims relevant to CPP
    • Prevent secondary brain injury: avoid hypoxia, hypotension, hypercapnia; treat raised ICP; maintain adequate CPP.
    • Maintain stable haemodynamics during laryngoscopy, pinning, incision, emergence (avoid ICP spikes).

Definitions and key equations

  • Cerebral perfusion pressure
    • CPP = MAP − ICP (or MAP − CVP, whichever is higher as downstream pressure).
    • MAP ≈ DBP + 1/3(SBP−DBP) (at normal HR).
  • Cerebral blood flow relationship
    • CBF = CPP / CVR (cerebrovascular resistance).
    • CMRO₂ (metabolic demand) influences CBF via flow–metabolism coupling.
  • Intracranial pressure (ICP)
    • Normal adult ICP ~ 5–15 mmHg; sustained >20–22 mmHg often treated in TBI.
    • Monro–Kellie: fixed cranial volume (brain, blood, CSF); compensatory reserve can be exhausted leading to steep ICP rises.

Physiology: determinants of CPP and CBF

  • Determinants of CPP
    • MAP: cardiac output, SVR, intravascular volume, vasoactive drugs, anaesthetic depth.
    • ICP: brain volume (oedema, tumour, haematoma), cerebral blood volume (PaCO₂, venous drainage), CSF volume (hydrocephalus, drainage).
    • Downstream pressure: if CVP > ICP (e.g., high PEEP, right heart failure), CPP ≈ MAP − CVP.
  • Autoregulation
    • Maintains relatively constant CBF across a MAP range (classically ~50–150 mmHg in healthy adults), via arteriolar vasoconstriction/dilatation.
    • Right shift in chronic hypertension; impaired/abolished in TBI, SAH, stroke, severe sepsis, hypercapnia, volatile anaesthetics at higher MAC.
    • If autoregulation lost: CBF becomes pressure-passive → hypotension causes ischaemia; hypertension increases CBF/CBV → raised ICP and haemorrhage risk.
  • CO₂ and O₂ reactivity
    • PaCO₂: potent modulator. Hypercapnia → vasodilation ↑CBF/CBV ↑ICP; hypocapnia → vasoconstriction ↓CBF (risk ischaemia).
    • Typical CBF change ~2–4% per 1 mmHg PaCO₂ change (within physiological range).
    • PaO₂: little effect until PaO₂ < ~50–60 mmHg → vasodilation ↑CBF; hypoxia is a major secondary insult.
  • Venous outflow and intrathoracic pressure
    • Head position neutral, 15–30° head-up, avoid tight ETT ties/neck flexion/rotation to improve jugular venous drainage and reduce ICP.
    • High PEEP, coughing/straining, pneumoperitoneum, Trendelenburg can increase CVP and ICP, reducing CPP.

Targets and evidence-informed thresholds (exam-oriented)

  • Traumatic brain injury (adult severe TBI, typical ICU practice)
    • Common CPP target: 60–70 mmHg (avoid <60; avoid aggressive >70 if it requires high-dose vasopressors/fluids due to ARDS risk).
    • Treat ICP when sustained >20–22 mmHg (context-dependent).
    • Avoid hypotension: SBP ≥100–110 mmHg (age-dependent) is commonly targeted to reduce secondary injury.
  • Subarachnoid haemorrhage and vasospasm (conceptual)
    • Maintain euvolaemia; induced hypertension may be used for delayed cerebral ischaemia/vasospasm under specialist guidance (CPP augmentation).
  • Stroke / ICH (principles)
    • Avoid hypotension; BP targets depend on pathology (e.g., ICH often requires BP reduction while preserving CPP).

Monitoring CPP and cerebral perfusion

  • Basic monitoring
    • Invasive arterial BP (level transducer at tragus/external auditory meatus if CPP is being calculated to approximate circle of Willis level).
    • ETCO₂ (and ABGs), SpO₂, temperature, glucose, Hb.
  • ICP monitoring (where indicated)
    • External ventricular drain (EVD): gold standard for ICP + allows CSF drainage (therapeutic).
    • Intraparenchymal fibreoptic/strain gauge: ICP monitoring only (no drainage).
    • Complications: infection, haemorrhage, malposition; EVD overdrainage can cause ventricular collapse/subdural collections.
  • Adjuncts to assess adequacy of perfusion/oxygenation
    • Jugular venous oximetry (SjvO₂): global balance of CBF vs CMRO₂; low suggests ischaemia, high may suggest hyperaemia or poor extraction.
    • Brain tissue oxygen (PbtO₂): focal oxygenation; low values may prompt CPP augmentation, oxygenation optimisation, ICP treatment.
    • Transcranial Doppler: flow velocity (vasospasm, autoregulation trends).
    • Near-infrared spectroscopy (NIRS): regional cortical oxygenation (limited specificity; trend monitor).

How to increase CPP (structured approach)

  • Step 1: Confirm numbers and artefact
    • Check arterial line damping/zeroing and level; check ICP waveform/zero; ensure correct CPP calculation (MAP at brain level).
  • Step 2: Raise MAP (if appropriate)
    • Treat reversible causes: anaesthetic overdose, hypovolaemia, arrhythmia, myocardial dysfunction, sepsis.
    • Vasopressors: noradrenaline commonly first-line; phenylephrine may reduce HR/CO; vasopressin adjunct in vasoplegia.
    • Fluids: aim euvolaemia; avoid excessive crystalloid causing oedema; consider blood if anaemia contributes to low oxygen delivery.
  • Step 3: Reduce ICP (often the most effective way to improve CPP)
    • Position: head up 15–30°, neutral neck; remove venous obstruction.
    • Ventilation: avoid hypercapnia; short-term mild hypocapnia can temporise impending herniation (bridge to definitive therapy).
    • Analgesia/sedation: prevent coughing/ventilator dyssynchrony; consider neuromuscular blockade if needed.
    • Osmotherapy: mannitol or hypertonic saline (consider haemodynamics, sodium/osmolality, renal function).
    • CSF drainage via EVD if present (follow local protocol; avoid overdrainage).
    • Temperature: treat pyrexia; consider targeted temperature management only under specialist protocols.
    • Definitive: evacuate mass lesion, decompressive craniectomy.

How to decrease CPP (when might you want to?)

  • Usually you aim to preserve CPP; deliberate reduction is uncommon and must be pathology-specific.
  • Examples
    • Unsecured aneurysmal SAH: avoid hypertension that may increase rebleeding risk (balance against ischaemia).
    • Intracerebral haemorrhage: BP reduction to limit haematoma expansion while maintaining adequate perfusion.

Anaesthetic implications (drugs and techniques)

  • Induction and airway
    • Goals: avoid hypoxia, hypotension, hypercapnia; blunt pressor response (opioid, lidocaine, beta-blocker, deepening anaesthesia as appropriate).
    • Ketamine: historically avoided in raised ICP; contemporary evidence suggests it can be used with controlled ventilation and co-anaesthetics; useful in hypotensive TBI.
    • RSI often required (trauma/full stomach). Maintain CPP during induction with vasopressor boluses/infusion as needed.
  • Maintenance
    • TIVA (propofol/remifentanil) provides good control of CMRO₂/CBF and facilitates neurophysiology; volatiles cause dose-dependent cerebral vasodilation and can increase ICP (especially >1 MAC).
    • Ventilation: target normocapnia unless temporising raised ICP; avoid hypoxia; avoid high mean airway pressures if ICP problematic.
    • Haemoglobin/oxygen delivery: avoid anaemia in patients at risk of cerebral ischaemia; transfusion threshold individualised (consider CPP/oxygenation monitors).
    • Fluids: isotonic crystalloids; avoid hypotonic fluids and dextrose-containing solutions (risk cerebral oedema/hyperglycaemia).
  • Emergence
    • Smooth emergence to avoid coughing/hypertension (ICP spikes). Consider deep extubation only in carefully selected patients; otherwise opioid/lidocaine/esmolol and good suctioning.
    • Post-op destination: ICU/HDU if ongoing ICP/CPP management, ventilation, or high risk of deterioration.
Define cerebral perfusion pressure and explain how you would calculate it in ICU.

Key marks are the equation, downstream pressure caveat, and correct referencing of MAP level.

  • CPP = MAP − ICP (or MAP − CVP if CVP > ICP).
  • Use invasive arterial BP; level the transducer at the tragus/external auditory meatus to approximate cerebral arterial pressure when head elevated.
  • ICP from EVD or intraparenchymal monitor; ensure correct zeroing and waveform validity.
A ventilated severe TBI patient has MAP 70 mmHg, ICP 28 mmHg. What is the CPP? What would you do?

This is a common calculation + management prioritisation question.

  • CPP = 70 − 28 = 42 mmHg (low).
  • Immediate actions: check artefact/zeroing; ensure oxygenation and normocapnia; ensure adequate sedation/analgesia and synchrony.
  • Treat ICP: head-up/neutral, drain CSF if EVD, osmotherapy (HTS/mannitol), consider brief mild hypocapnia only as a bridge if herniation suspected.
  • Raise MAP with noradrenaline after assessing volume status; avoid excessive fluids; target CPP commonly 60–70 mmHg per local protocol.
  • Escalate: CT to exclude mass lesion; consider decompression if refractory.
Describe cerebral autoregulation and how it affects your choice of blood pressure targets.

Examiners want the concept of pressure-passive flow when autoregulation is impaired.

  • Autoregulation: arteriolar responses maintain near-constant CBF across a MAP range (classically ~50–150 mmHg in healthy adults).
  • Chronic hypertension shifts the curve right → higher MAP needed to maintain CBF.
  • In TBI/SAH/stroke autoregulation may be impaired → CBF becomes pressure-passive; hypotension risks ischaemia, hypertension risks hyperaemia/raised ICP/bleeding.
How does PaCO₂ affect ICP and CPP? When is hyperventilation appropriate?

Need to mention vasoreactivity, effect on CBV/ICP, and ischaemia risk.

  • Hypercapnia → cerebral vasodilation → ↑CBF/CBV → ↑ICP → ↓CPP (if MAP constant).
  • Hypocapnia → vasoconstriction → ↓CBF/CBV → ↓ICP → ↑CPP, but may cause cerebral ischaemia (especially injured brain).
  • Hyperventilation is appropriate as a short-term temporising measure in impending herniation while definitive ICP-lowering therapy is instituted.
List methods to reduce ICP and explain which will also improve CPP.

CPP improves when ICP falls (CPP = MAP − ICP).

  • Positioning (head-up, neutral neck), optimise venous drainage.
  • Sedation/analgesia ± neuromuscular blockade to prevent coughing/straining.
  • CSF drainage via EVD.
  • Osmotherapy: mannitol or hypertonic saline.
  • Optimise ventilation (avoid hypercapnia; brief mild hypocapnia only as bridge).
  • Definitive surgical decompression/evacuation of mass lesion.
An arterial line is zeroed at the heart but the patient is 30° head-up. How does this affect CPP calculation?

This is a classic FRCA viva trap about transducer height and hydrostatic gradient.

  • If the arterial transducer is at the heart while the brain is higher, the displayed MAP overestimates cerebral arterial pressure.
  • Therefore calculated CPP will be overestimated and true CPP may be lower than you think.
  • Level the arterial transducer at the tragus/external auditory meatus when managing CPP.
Discuss the choice of vasopressor to augment CPP in severe TBI.

Examiners want a reasoned choice and awareness of effects on CO and cerebral circulation.

  • Noradrenaline commonly first-line: increases MAP with less reflex bradycardia than pure alpha agonists; supports CPP.
  • Phenylephrine: raises MAP but may reduce HR and CO; may be acceptable if tachycardic but can reduce systemic oxygen delivery.
  • Adrenaline: increases MAP and CO but more arrhythmogenic and increases lactate; consider in myocardial dysfunction with hypotension.
  • Vasopressin: adjunct in vasoplegia; watch for splanchnic/skin ischaemia at high doses.
Explain why increasing MAP does not always increase CBF in brain-injured patients.

This tests understanding of autoregulation, ICP, and microcirculatory failure.

  • If autoregulation intact, raising MAP may trigger vasoconstriction → little change in CBF.
  • If raising MAP increases cerebral blood volume (pressure-passive) it may increase ICP, offsetting CPP gains.
  • Microvascular obstruction, oedema, vasospasm, or impaired flow–metabolism coupling can limit effective tissue perfusion despite higher CPP.
What are the risks of targeting a high CPP (e.g., >70–80 mmHg) in TBI?

Classic question: benefits vs harms of aggressive CPP augmentation.

  • May require high-dose vasopressors and large fluid volumes → risk of pulmonary oedema/ARDS and cardiac strain.
  • If autoregulation impaired, hypertension may increase CBF/CBV → raised ICP and risk of haemorrhagic progression.
  • May worsen cerebral oedema (hydrostatic effects) in leaky BBB states.
Describe methods to assess adequacy of cerebral perfusion beyond CPP.

CPP is a surrogate; the question probes multimodal monitoring.

  • PbtO₂ monitoring (focal tissue oxygenation).
  • SjvO₂ (global oxygen extraction balance).
  • TCD (flow velocities; vasospasm; autoregulation indices).
  • NIRS (regional cortical oxygenation trends).
  • Clinical: pupillary changes, motor response (if examinable), seizures; imaging (CT perfusion where used).
A patient on high PEEP has MAP 75, ICP 15, CVP 22. What is the effective CPP and why?

Tests the downstream pressure concept.

  • Downstream pressure is the higher of ICP and CVP; here CVP (22) > ICP (15).
  • Effective CPP ≈ 75 − 22 = 53 mmHg.
  • High intrathoracic pressure elevates CVP, impairs cerebral venous drainage, can increase ICP and reduce CPP.

0 comments